Why Carter's Stock Slipped Today
An analyst made a significant price target cut.
CRI - Carter's Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$40.75
DETAILS
HIGH:
$42.00
LOW:
$40.00
MEDIAN:
$40.50
CONSENSUS:
$40.75
UPSIDE:
28.02%
Stock News
Carter’s (NYSE:CRI) Shares Gap Down After Analyst Downgrade
Carter's, Inc. (NYSE: CRI - Get Free Report) gapped down prior to trading on Monday after Wells Fargo and Company lowered their price target on the stock from $42.00 to $30.00. The stock had previously closed at $32.36, but opened at $30.90. Wells Fargo and Company currently has an equal weight rating on the stock. Carter's
Should Value Investors Buy Carter's (CRI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is It Too Late to Buy Carter's Inc (CRI) After 4.7% Rally? GF Value Says Undervalued
On October 06, 2026, Carter's Inc (CRI) shares rose 4.7% to a current price of $33.83, within a 52-week range of $27.15 to $44.44. This price movement reflects
Carter's Stock Trading at a Discount: What's the Next Best Move?
CRI trades at a discount as improving retail, wholesale and digital trends support growth despite consumer, promotional and tariff pressures.
In an Age of Comparison, Carter's and Dr. Becky Kennedy Team Up to Help Kids Stay Confident
ATLANTA--(BUSINESS WIRE)--Carter's, Inc. (NYSE: CRI), Carter's, Inc., North America's largest and most-enduring apparel company exclusively for babies and young children, today announced a partnership with clinical psychologist, parenting expert and Good Inside Founder and CEO Dr. Becky Kennedy to launch The Childhood Confidence Project, a first-of-its-kind initiative giving parents research-backed tools to help their children build confidence and individuality as they grow. Carter's believes e.
Are Investors Undervaluing Carter's (CRI) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Implied Volatility Surging for Carter's Stock Options
Investors need to pay close attention to CRI stock based on the movements in the options market lately.
Carter's: Attractive As Tariff Headwind Inflects
Carter's (CRI) remains a buy after a recent sell-off, with shares trading at attractive 9x earnings and positive same-store sales momentum. A $132 million tariff refund and improved working capital have fortified CRI's balance sheet, enabling debt reduction and securing its 3.3% dividend yield. New CEO Sharon Price John is positioned to drive growth, with Gen Z traction and easing tariff headwinds supporting a margin inflection in H2.
Children's clothing retailer Carter's is rebranding to appeal to a new generation of parents
Children's clothing brand Carter's is announcing a rebrand as it tries to keep up with the modern parent and its core customer base. The overall company has struggled over the past few years as it faces elevated product costs and tariffs, with its stock sinking more than 50% over the past three years.
Carter's Shines a New Light on Childhood with Evolved Brand Promise, Refreshed Identity and “Watch Them Glow” Campaign
ATLANTA--(BUSINESS WIRE)--Carter's, Inc. (NYSE: CRI), North America's largest and most-enduring apparel company exclusively for babies and young children, today unveiled an evolution of its namesake Carter's brand anchored by a new brand promise, or North Star, to “Let every child's light shine.” This evolution comes as the experience of raising children continues to change. Parents and caregivers are navigating more information, advice and expectations, while placing greater emphasis on giving.
Carter's Growth Supported by Brands, Digital Efforts & Cost Savings
CRI's growth strategy centers on brand innovation, digital expansion and productivity initiatives to strengthen sales and offset tariff pressures.
Carter's Introduces Not-So-Scary Monsters to Help Make Bedtime Easier and More Fun for Families
ATLANTA--(BUSINESS WIRE)--Bedtime isn't always the peaceful wind-down parents hope for. Nearly 70% of parents of children 2 to 6 years old say their child's bedtime routine is at least somewhat stressful, according to new Carter's research. From getting ready for bed and turning out the lights to staying in bed and falling asleep, parents say challenges can show up throughout the nightly routine. In their effort to “make bedtime the best time” Carter's is launching Not-So-Scary Monsters, a new.
Should Value Investors Buy Carter's (CRI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Carter's Growth Story Gains Strength: Is More Upside Ahead?
CRI's recovery gains strength as sales growth, retail momentum and digital investments support improving execution and a stronger growth trajectory.
Brokerages Set Carter’s, Inc. (NYSE:CRI) Price Target at $41.17
Carter's, Inc. (NYSE: CRI - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, four have assigned a buy rating and one has
Carter's highlighted as Zacks Bull and Agnico Eagle Bear of the Day
Chicago, IL – August 26, 2026 – Zacks Equity Research shares Carter's CRI as the Bull of the Day and Agnico Eagle Mines AEM as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Rocket Companies' RKT, UWM Holdings Corp. UWMC and PennyMac Financial Services, Inc. PFSI.
Carter's (CRI) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Carter's (CRI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
New Strong Buy Stocks for August 24th
FHI, NVT, NESR, CRD.B and CRI have been added to the Zacks Rank #1 (Strong Buy) List on August 24th, 2026.
Best Income Stocks to Buy for August 24th
CURI, CRI and CRD.B made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 24th, 2026.
Price Targets
Carter's initiated with an Outperform at BMO Capital
$40.00
(was $32.28)
Kelly Crago
·
BMO Capital
BMO Capital Starts Carter's (CRI) at Outperform
$40.00
(was $32.28)
Capital One Financial
Carter's upgraded to Equal Weight from Underweight at Wells Fargo
$42.00
(was $41.10)
Wells Fargo
Carter's price target raised to $41 from $40 at UBS
$41.00
(was $35.33)
UBS
Carter's price target raised to $33 from $28 at Wells Fargo
$33.00
(was $37.57)
Wells Fargo
Carter's upgraded to Neutral from Sell at Goldman Sachs
$38.00
(was $36.79)
Goldman Sachs
Carter's price target raised to $40 from $33 at UBS
$40.00
(was $41.60)
UBS
Carter's price target raised to $29 from $26 at Goldman Sachs
$29.00
(was $35.63)
Goldman Sachs
Carter's initiated with a Sell at Goldman Sachs
$26.00
(was $33.35)
Goldman Sachs
Carter's price target raised to $33 from $26 at UBS
$33.00
(was $32.50)
UBS
Carter's price target raised to $25 from $22 at Wells Fargo
$25.00
(was $32.51)
Wells Fargo
Carter's price target raised to $26 from $23 at Barclays
$26.00
(was $32.98)
Barclays
Carter's price target raised to $23 from $22 at Barclays
$23.00
(was $29.74)
Barclays
Carter's initiated with an Underweight at Barclays
$25.00
(was $33.87)
Paul Kearney
·
Barclays
Carter's (CRI) PT Lowered to $60 at Evercore ISI
$60.00
(was $57.26)
Warren Cheng
·
Evercore ISI
CFRA Upgrades Carter's (CRI) to Buy
$84.00
(was $70.01)
Zachary Warring
·
CFRA